HHT is an autosomal dominant genetic disorder, with ~90% of the patients associated with heterozygous mutations of ACVRL1 or ENG genes, while ~10% of cases also affect genes that encode components of the BMP9/ALK1 signaling pathway [2,3,4]. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.